MEDP Medpace Holdings Inc
Company Analysis
Latest News
🟢 Medpace Holdings is trading 4% up today on defensive healthcare-sector strength
Medpace Holdings is trading at $619.60, up +4.06% as defensive healthcare-sector strength supports the move. - No major company-specific announcement or...
Medpace Shares Sink, CEO Sells $10 Million Amid Valuation Fears
Medpace Holdings shares fell on August 27, 2026. CEO August Troendle sold approximately $10 million in company stock. The transaction fueled investor concerns...
🟢 Medpace Holdings is trading 6.4% up in pre-market amid broader risk-on sentiment after Nvidia’s strong results
Medpace Holdings is trading at $658.43 (+6.36%) in pre-market, mainly amid broader risk-on sentiment after Nvidia’s strong results. - No clearly reported...
🔴 Medpace Holdings is trading 8.3% down in pre-market amid valuation concerns and profit-taking
Medpace Holdings is trading 8.3% down now at $541.62 in pre-market as broad risk-off selling continued following the August 18, 2026 technology-led market...
🔴 Medpace Holdings is trading 18.85% down in after-hours trading amid broad risk-off selling
Medpace Holdings is trading 18.85% down at $479 now after broad risk-off selling, following the regular session close at $590.30 on August 18, 2026. - The...
🔴 Medpace Holdings is trading 5% down in pre-market as Nasdaq Composite is down 1.12%
Medpace Holdings is trading at $565.00 (-5.38%) in pre-market as weaker markets pressure equities. - The Nasdaq Composite is down 1.12%, with broader risk...
🟢 Medpace Holdings is trading 46% up in pre-market with no company-specific catalyst identified
Medpace Holdings is trading 45.88% up at $848.93 in pre-market after no company-specific announcement dated August 14, 2026 was identified. - Recent coverage...
Medpace faces legal investigations, over alleged inflated growth projections
Bronstein, Gewirtz & Grossman, LLC and Kuehn Law, PLLC launched investigations into Medpace Holdings on August 10, 2026. The probes examine whether the company...
🔴 Medpace Holdings is trading 14.5% down today despite no company-specific news amid broader market weakness
Medpace Holdings is trading at $500.00 (-14.52%) in after-hours trading despite no company-specific earnings release, guidance update, or major announcement...
🔴 Medpace Holdings is trading 8.3% down today amid thin after-hours liquidity and broader market weakness
Medpace Holdings is trading at $536.31 (-8.31%) in after-hours trading following a regular-session close of $584.93, with no company-specific earnings or major...
Medpace's second quarter 2026 results beat estimates, driven by a 28.2% surge in net new business awards.
Medpace reported second quarter 2026 revenue of $707.3 million, up 17.2% year-over-year, with diluted EPS of $4.25, a 37.1% increase from the prior-year...
Medpace Holdings Inc Q2 2026 Earnings Preview: What Analysts Expect on July 22, 2026
Wall Street projects Medpace Holdings to report second-quarter revenue of approximately $690.7 million and earnings per share of $4.08, with the current stock...
Medpace Downgraded to Neutral, Baird Flags Backlog and Valuation Concerns
Baird downgraded Medpace Holdings Inc. (MEDP) to Neutral from Outperform. The firm simultaneously raised its price target for the stock to $547 from $477. A...
🔴 MEDP is trading 4.3% down today after Jefferies cut its rating to Hold on valuation concerns
MEDP is trading 4.3% down at $522.99 after Jefferies downgraded the stock from Buy to Hold, citing valuation concerns and potential downside risk. • Jefferies...
🔴 MEDP is trading 5.7% down today after Jefferies downgrade on valuation concerns
MEDP is trading 5.7% down at $515.00 after Jefferies downgraded the stock from Buy to Hold, citing a stretched valuation and significant downside risk. •...
Medpace Downgraded to Hold, Jefferies Cites Stretched Valuation After 77% Surge
Jefferies downgraded Medpace Holdings Inc. (NASDAQ:MEDP) from Buy to Hold. The firm simultaneously increased its price target from $490.00 to $515.00. Analysts...
🔴 MEDP is trading 11.9% down today as shares adjust after recent volatility and growth concerns
MEDP is trading 11.9% down at $479 in pre-market as shares adjust after recent volatility and growth-deceleration concerns. • The decline gives back a portion...
🟢 MEDP is trading 4.1% up today as a rebound within its recent range
MEDP is trading 4.1% up at $551.02 today, appearing to rebound within its recent trading range following a period of volatility. • No new company-specific...
🟢 MEDP extends move to 5.7% up
MEDP is trading at $500.60, up 5.7% versus the comparison close of $473.48 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MEDP is trading 4.7% up today with no clear company-specific catalyst
MEDP is trading 4.7% up today at $495.64 amid light news flow and a lack of clear company-specific catalysts. • The move appears idiosyncratic, with broader...